
BI-3812
CAS No. 2166387-64-8
BI-3812( BI3812 | BI 3812 )
Catalog No. M13458 CAS No. 2166387-64-8
A highly potent and efficacious BCL6 inhibitor that potently inhibits the interaction of the BTB/POZ domain of BCL6 with several co-repressors in vitro with IC50 of <3 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 149 | Get Quote |
![]() ![]() |
5MG | 237 | Get Quote |
![]() ![]() |
10MG | 402 | Get Quote |
![]() ![]() |
25MG | 665 | Get Quote |
![]() ![]() |
50MG | 888 | Get Quote |
![]() ![]() |
100MG | 1251 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBI-3812
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent and efficacious BCL6 inhibitor that potently inhibits the interaction of the BTB/POZ domain of BCL6 with several co-repressors in vitro with IC50 of <3 nM.
-
DescriptionA highly potent and efficacious BCL6 inhibitor that potently inhibits the interaction of the BTB/POZ domain of BCL6 with several co-repressors in vitro with IC50 of <3 nM; inhibits the BCL6/Co-repressor complex formation with IC50 of 40 nM in vitro.
-
In Vitro——
-
In Vivo——
-
SynonymsBI3812 | BI 3812
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2166387-64-8
-
Formula Weight558.036
-
Molecular FormulaC26H32ClN7O5
-
Purity>98% (HPLC)
-
SolubilityDMSO : 20.83 mg/mL 37.33 mM; H2O : < 0.1 mg/mL
-
SMILESO=C(C1CCN(C2=NC=C(Cl)C(NC3=CC4=C(N(C)C(C(OCC(NC)=O)=C4)=O)C(OC)=C3)=N2)CC1)N(C)C
-
Chemical Name1-(5-chloro-4-((8-methoxy-1-methyl-3-(2-(methylamino)-2-oxoethoxy)-2-oxo-1,2-dihydroquinolin-6-yl)amino)pyrimidin-2-yl)-N,N-dimethylpiperidine-4-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kerres N, et al. Cell Rep. 2017 Sep 19;20(12):2860-2875.
molnova catalog



related products
-
SW076956
SW076956 is a small molecule that selectively disrupt Beclin 1/Bcl-2 binding as compared to Bax/Bcl-2 and Bim/Bcl-2 binding and induces autophagic flux at concentrations with minimal cytotoxicity.
-
S-63845
S-63845 (S63845)?is a highly potent, selective Mcl-1 inhibitor with Kd of 0.19 nM.
-
FX1
A potent, specific BCL6 BTB domain inhibitor with Kd of 7 uM, binds with a greater affinity than the natural BCL6 ligand SMRT (Kd=30 uM).